The UK is witnessing a noticeable surge in interest surrounding copyright substances. Beyond the familiar use of psilocybin and LSD, investigators and adventurers are increasingly exploring less-charted frontiers, particularly copyright and the relatively new cannabinoid, cannabigerol. The evolving